MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Unveil Adaptive Design for Berubicin Phase 2 Clinical Trial in Nov. 12 Webinar
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its plans to issue a video update…
-
Predictive Oncology (NASDAQ: POAI) Subsidiary’s HSC Technology Optimization Solution Offers Unparalleled Results, Benefits
POAI subsidiary Soluble Biotech’s optimization solution shaves time and cost off of traditional options offered by competition Results garnered from company’s HSC optimization are unparalleled in field Soluble Biotech lands first major contract, signifying major…
-
Acquisition Strategy Paying Off for Sustainable Green Team, Ltd. (SGTM) Through Increased Profits, International Expansion
National Storm Recovery Inc. acquired Mulch Manufacturing Inc. several months ago to create SGTM SGTM diverts storm waste from landfills to create attractive next-generation products that benefit the environment Mulch Manufacturing recently secured many new…
-
MissionIRNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction
CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an…
-
Knightscope, Inc. Is ‘One to Watch’
Knightscope is a leader in the development of autonomous security capabilities and is on target to disrupt the $500 billion security industry The company is presently in the process of raising up to $25 million…
-
VistaGen Therapeutics’ (NASDAQ: VTGN) New Generation Phase 3 Drug Candidate for Social Anxiety Disorder Gains Importance Amid FDA Wariness of Benzodiazepines
VistaGen has three innovative CNS drug candidates which target a wide range of anxiety, depression and neurological disorders PH94B, the Company’s most advanced drug candidate, is entering Phase 3 development for acute, on-demand treatment of…
-
SRAX Inc.’s (NASDAQ: SRAX) Sequire Delivers Valuable Insights into Consumer Behaviors, Aids Publicly Traded Companies in Investor Growth
Since its launch in early 2019, Sequire has gained 1 million active investors, traders from 91 public companies New name — Sequire — represents platform’s main objective to acquire, secure investors for publicly traded companies…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with a high unmet medical need, today announced the appointment of Dr. Khalid Islam to its…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Its Alkaline88 Product Reaches No. 1 Spot at KeHE Winter Show
The Alkaline Water Company’s (NASDAQ: WTER) (CSE: WTER) flagship brand, Alkaline88(r), was the No. 1 item by cases sold at the recent KeHE Virtual Winter Show. The company produces premium bottled alkaline water, flavor-infused waters and…
-
MissionIRNewsBreaks– DarioHealth Corp. (NASDAQ: DRIO) to Report Q3 2020 Financial Results, Host Conference Call
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced that it will release financial results for its second quarter ended September 30, 2020, on Thursday, Nov. 12, 2020, as well as…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reschedules Webcast for Nov. 4, 2020
Energy Fuels (NYSE American: UUUU) (TSX: EFR) on Tuesday announced that, due to technical issues, its conference call and webcast originally scheduled for Nov. 3, 2020, has been postponed to be held at 4:00 pm…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, was featured in an institutional research report by Craig-Hallum Capital…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in Stock2Me Podcast
VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork (“IBN”) solution to…
-
Sustainable Green Team Ltd. (SGTM) Subsidiary — Mulch Manufacturing — Awarded String of Contracts
Mulch Manufacturing has signed mulch supplier contract with Vero Beach, Florida This — and other recent contracts — made possible due to SGTM’s recent completion of construction on its Florida Waste Management facility Sustainable Green…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Call, Live Webcast to Discuss Q3 2020 Results, Clinical Pipeline
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, today announced that it will host a conference call and…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Achieves Major Milestone in US REE Production
Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced that the company has produced a rare earth element (“REE”) carbonate concentrate (“REE Concentrate”) on a pilot scale at its 100% owned White Mesa Mill (the…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Filing Date for Second-Quarter Financial Report
Canopy Rivers (TSX: RIV) (OTC: CNPOF) has set a filing date for its Q2 2021 financial results. The company plans to release its Q2 FY 2021 financial report on Nov. 9, 2020, before the market…
-
MissionIRNewsBreaks – Cybin Corp. Paves Path to Profitability with Health-Care Veteran at the Helm
Cybin Corp., a Canada-based, life-science company advancing psychedelic pharmaceuticals, recently announced the appointment of Doug Drysdale as its CEO (https://ibn.fm/UTTdr). Drysdale, named an Ernst and Young Entrepreneur of the Year in 2012, brings more than…
-
MissionIRNewsBreaks – Why Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Is ‘One to Watch’
Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options. A recent article discussing the company…
-
CYBIN Corp. Set to Benefit from Growing Research, Interest in Psychedelics
Backed by an anonymous donor, Berkeley launches a center for psychedelic science and public education Berkley follows examples of other notable universities such as Johns Hopkins in Maryland, Imperial College in London, and Canadian Centre…
-
Knightscope, Inc. Creating Change in the Security Industry Through Proprietary Technology to Assist Law Enforcement and Private Security
Knightscope recently named Ms. Mallorie Burak as Executive Vice President and Chief Financial Officer The company’s autonomous security robots use proprietary technology, combining robotics, self-driving capabilities, and artificial intelligence Game changing technology has now been…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Secures $6.9M in Private Placement
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, earlier this year announced the closing of a private placement financing (the “offering”). According to the update, AzurRx secured…
-
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Preclinical Study Data Show Drug Combo’s Innovative Potential in Fight Against Major Depressive Disorder
Study results have exciting therapeutic potential across wide range of CNS indications. VTGN focused on developing new generation of medications to treat anxiety, depression and more. Company committed to finding treatment to help estimated 264…
-
MissionIRNewsBreaks – Knightscope Inc. Secures Purchase Order from California Water District
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, recently announced its receipt of a purchase order from a California Water District to help protect the…
-
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Completion of Drug Manufacturing for Brain Cancer Trial
Houston-based CNS Pharmaceuticals is preparing to launch Phase 2 clinical testing of a novel brain cancer-fighting drug candidate called Berubicin early next year The biopharmaceutical company recently announced that a U.S.-based company contracted to make…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2020 Results, Notes Significant Strides on Multiple Initiatives
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium in the United States, on Friday reported its financial results for the quarter ended September 30, 2020. In addition, Energy Fuels will host…
-
MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) Secures New, Repeat BolaWrap(R) Orders, Appoints New Director of International Sales
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, announced receipt of new and repeat domestic orders for BolaWrap(R) products and accessories. According to the update, the company has received numerous recent orders from…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Sells Remaining MD Ownership Stake
SRAX (NASDAQ: SRAX), an innovative fintech solutions provider that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire, today announced that it has sold its remaining interest in the SRAX MD…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Launch of New Branding for Upcoming Combination Clinical Trials
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for cancer and diabetes patients, today announced the launch of new branding for its upcoming oncology clinical trials. The trials combine Genprex’s lead…
-
MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) Announces Q3 2020 Results, Appointment of Interim CEO and Chief Govt Affairs Officer
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, on Thursday announced results for its third quarter ended September 30, 2020. Among the Q3 highlights, the company reported a 275% growth in net sells,…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in BioWorld Article
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in a recent BioWorld article titled, “CBC-funded Affamed merges with Everinsight, extends…
-
MissionIRNewsBreaks – Sustainable Green Team Ltd. (SGTM) Announces Audit Completion, Preparation for Uplisting, Receipt of New Order from 7-Eleven Stores
Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, announced completion of its two-year 2018 and 2019 audit to commence the form-10 process to become fully…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Addition of BettermentRS, a Leading CBD Distributor
The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products, has added health and wellness, CBD-focused, direct-store delivery (DSD) distributor BettermentRS to its list of…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Conditional FDA Acceptance of Proprietary Name for Lead Drug Candidate
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has received conditional FDA acceptance of the proprietary name REQORSA(TM), its lead drug candidate for treatment of…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Completion of Drug for Clinical Trials
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has through its European manufacturer, BSP Pharmaceuticals S.p.A. (“BSP”), finished manufacturing…
-
SRAX Inc. (NASDAQ: SRAX) CEO and LD Micro President Discuss Impending Synergistic Acquisition as BIGtoken Announces New Additions to Board of Directors
SRAX CEO Christopher Miglino recently joined LD Micro president Chris Lahiji on Stock2Me podcast, discussed SRAX’s recent purchase of LD Micro’s business SRAX’s Miglino noted that acquisition of LD Micro would allow SRAX’s investor intelligence…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Secures Financing to Fund Phase 2 Clinical Trials and Phase 3 Preparations
AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company, in July entered into a convertible preferred stock and warrant securities purchase agreement with certain accredited and institutional investors relating to the private placement of certain shares of…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Present at Zooming with LD
SRAX (NASDAQ: SRAX), an innovative fintech solutions provider that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire, today announced that it will present virtually at Zooming with LD. SRAX’s presentation…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Releases Q3 2020 Financials, Marks Record Numbers
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform,has released financial numbers for its third quarter. Financial highlights include third-quarter revenues up by 174% to $6.3 million, compared to revenue of $2.3 million…
-
MissionIRNewsBreaks – Knightscope Inc. Appoints Experienced Financial Exec as CFO, Announces Online Opportunity to Invest
Knightscope, a developer of advanced physical security technologies utilizing fully autonomous robots focused on enhancing U.S. security operations, today announced the appointment of Mallorie Burak as the company’s executive vice president and chief financial officer.…
Search Articles
Latest Articles
- BluSky AI Inc. (BSAI): Democratizing AI Through Modular Infrastructure and a New Neocloud That Scales from Startup to Enterprise
- MissionIRNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Integrates Chainlink Data Services Into Tokenized Money Market Fund
- Brera Holdings PLC (NASDAQ: BREA) Gains Outperform Rating from PartnerCap Securities, Price Target Set at $11.50
- MissionIRNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Positioned to Drive RapidSX(TM) Toward Commercial Launch